Endra Life Sciences amends merger agreement and increases loan capacity

Fitch upgrades American Express to ’A+’ on fee business strength and premium reach

Investing.com · News 8m ago

Opinion | The Other Threat to Fed Independence

Dow Jones · Markets 10m ago

United Therapeutics CEO Martine Rothblatt disposes of $3.9m in stock

Investing.com · News 11m ago

Kymera Therapeutics CEO Nello Mainolfi sells $3.4 million in stock

Investing.com · News 11m ago

SKYX Platforms receives Nasdaq notice on board independence following director’s passing

Investing.com · News 11m ago

Alaska LNG could cost more than double Gulf Coast rivals, raising questions over economics

Investing.com · News 14m ago

Pelthos Therapeutics elects directors and approves new equity plan at annual meeting

Investing.com · News 15m ago

Aethlon Medical shareholders approve equity plan amendments and board elections

Investing.com · News 20m ago

Hertz Global Holdings announces board changes with three new director appointments

Investing.com · News 25m ago

Mexico stocks lower at close of trade; S&P/BMV IPC down 0.60%

Investing.com · News 27m ago